Company intelligence / Profile preview

Jinyu Bio-technology

Hohhot, Inner Mongolia, Chinajinyubiotech.com ↗

Ownership: Private
Employees: ~1400
Development stage: Commercial

Overview

Jinyu Bio‑technology is the largest animal vaccine company in China with a comprehensive portfolio covering pigs, cattle, sheep, poultry, waterfowl, and pets. It leads the market in foot-and-mouth disease vaccines. The company has also developed a tocilizumab biosimilar approved in China for rheumatoid arthritis as of October 2024. Its R&D emphasizes innovation with over ¥250–300 million annual investment and more than thirty patents filed per year recently. The company maintains high quality standards including ISO13485 and GMP compliance.

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: Animal vaccine (Biologic)Diagnostic kit (Diagnostic)Therapeutic agent (Small molecule and/or Biologic)Protein therapeutics (Biologic)Monoclonal antibodyBiosimilar
Industry: Biotech

Drug pipeline

1 asset

Combined Foot and Mouth Disease (Type O and A), Bovine Viral Diarrhea and Bovine Infectious Rhinotracheitis Inactivated Vaccine

Preclinical

Partnerships

Taizhou Mabtech Pharmaceutical Co., Ltd.Mongolia (export partner)Bangladesh (export partner)Egypt (export partner)

Beyond the preview

Go deeper on Jinyu Bio-technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jinyu Bio-technology.

Explore the full profile